Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 364

Results For "india"

3725 News Found

Panacea Biotec to manufacture 10 crore doses per year of Sputnik V
News | May 24, 2021

Panacea Biotec to manufacture 10 crore doses per year of Sputnik V

First batch produced at Panacea Biotec’s facilities at Baddi will be shipped to the Gamaleya Center for quality control and full scale production of the vaccine is due to start this summer


Five manufacturers get license to produce Black Fungus drug
News | May 23, 2021

Five manufacturers get license to produce Black Fungus drug

NATCO Pharmaceuticals, Hyderabad; Alembic Pharmaceuticals, Vadodara; Gufic Biosciences Ltd., Gujarat; Emcure Pharmaceuticals, Pune; and Lyka, Gujarat are new manufacturers


Bharat Parenterals receives license for Favipiravir Oral Suspension
News | May 23, 2021

Bharat Parenterals receives license for Favipiravir Oral Suspension

The product patent has been already filed under fast track approval


Orchid Pharma develops new molecule OCID-5090
News | May 23, 2021

Orchid Pharma develops new molecule OCID-5090

Allecra Therapeutics would now either directly or through out license file for NDA of this molecule.


Govt. monitoring supply of COVID-19 essential drugs
News | May 21, 2021

Govt. monitoring supply of COVID-19 essential drugs

Availability of drugs is being monitored by implementing a three-pronged strategy of supply chain management, demand side management, and affordability.


Cipla launches Covid-19 RT-PCR test Viragen
News | May 21, 2021

Cipla launches Covid-19 RT-PCR test Viragen

This test is designed for the qualitative detection of nucleic acid from SARS-CoV-2 in the upper and lower respiratory specimens from individuals suspected of COVID-19


Dishman Carbogen Amcis announces successful results for treatment for vitamin D deficiency
News | May 21, 2021

Dishman Carbogen Amcis announces successful results for treatment for vitamin D deficiency

Researchers observed that a form of vitamin D, known as 25-hydroxyvitamin D3 (Calcifediol), was absorbed faster and better than the same dose of vitamin D.


NATCO signs licensing agreement with Lilly for Baricitinib
News | May 18, 2021

NATCO signs licensing agreement with Lilly for Baricitinib

Natco has withdrawn its application filed with the Indian Patent Office, seeking Compulsory License against Lilly for Baricitinib for Covid-19 in India


Sputnik V launch to lift near-term outlook for Dr. Reddy's Labs: HDFC Securities
News | May 18, 2021

Sputnik V launch to lift near-term outlook for Dr. Reddy's Labs: HDFC Securities

Dr. Reddy's has the rights to distribute 250mn doses in India


Outlook intact for Dr. Reddy's Laboratories : ICICI Securities
News | May 18, 2021

Outlook intact for Dr. Reddy's Laboratories : ICICI Securities

India sales grew 23.5% YoY with consolidation of Wockhardt products